Agents targeting VEGF axis like bevacizumab, axitinib, lenvatinib, pazopanib, ramucirumab, sunitinib and vandetanib has been approved for the treatment of various cancers including colorectal cancer, non-small cell lung cancer, cervical cancer,ovarian cancer. Here, VEGFA is linked to colorectal cancer.